Search

Your search keyword '"Hmamouchi I"' showing total 240 results

Search Constraints

Start Over You searched for: Author "Hmamouchi I" Remove constraint Author: "Hmamouchi I"
240 results on '"Hmamouchi I"'

Search Results

2. AB0779 FACTORS DETERMINING THE SWITCH OF THE FIRST BIOLOGICAL TREATMENT IN RHEUMATOID ARTHRITIS: DATA FROM THE MOROCCAN RBSMR REGISTRY

3. AB0936 THE INCIDENCE OF FUNGAL INFECTIONS IN PATIENTS WITH SPONDYLOARTHRITIS UNDER BIOTHERAPY IN THE MOROCCAN REGISTRY OF BIOTHERAPY: 3-YEAR FOLLOW-UP

4. AB0029 NO PREDICTIVE EFFECT OF OBESITY ON CLINICAL RESPONSE IN PATIENTS WITH RA AND SpA AFTER 3 YEARS OF BIOLOGIC DRUGS: A MULTICENTER STUDY

5. POS0879 EXPLORING DIAGNOSTIC TIMELINES: A CROSS-SECTIONAL STUDY OF REFERRAL AND DIAGNOSTIC DELAYS OF PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES

7. AB0759 USING MACHINE LEARNING TO PREDICT SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGIC THERAPIES

8. Épuisement professionnel chez 445 rhumatologues pratiquant dans les pays arabes : évaluation de la prévalence et identification des facteurs prédictifs

9. L’apprentissage automatique pour prédire la rémission prolongée chez les patients suivis pour une polyarthrite rhumatoïde sous biothérapie

10. Efficacité des biothérapies chez les patients atteints de SPA en fonction de l’âge des patients : données du registre marocain RBSMR

11. Efficacité des biothérapies chez les patients atteints de SPA en fonction du sexe des patients : données du registre marocain RBSMR

12. Tuberculose active sous biothérapies chez les patients atteints de spondyloarthrites : résultats du registre marocain des biothérapies (RBSMR) à 3 ans de suivi

14. AB1586 THE RHEUMATOLOGY WORKFORCE IN THE ARAB COUNTRIES: WHAT IS THE CURRENT STATUS AND WHAT ARE THE PROJECTED UNMET NEEDS?

15. AB0969 FAILURE OF THE FIRST BIOLOGIC IN PATIENTS WITH SPONDYLOARTHRITIS: DATA FROM THE MOROCCAN RBSMR REGISTRY

16. POS1542 THE PSORIATIC ARTHRITIS IMPACT OF DISEASE (PSAID-12) QUESTIONNAIRE IS VALID IN ARABIC AND STRONGLY LINKED TO DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN ARAB-SPEAKING COUNTRIES: AN ARLAR INITIATIVE

17. AB1581 HIGH PREVALENCE OF BURNOUT SYNDROME AMONG RHEUMATOLOGISTS PRACTICING IN ARAB COUNTRIES: AN ARLAR MULTINATIONAL STUDY IN 394 RHEUMATOLOGISTS

18. AB1148 PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF PSORIATIC ARTHRITIS APPEAR MORE IN AGREEMENT IN ARAB COUNTRIES THAN PREVIOUSLY REPORTED ELSEWHERE – AN INTERNATIONAL STUDY UNDER THE AEGIS OF ARLAR

19. AB1055 COMORBIDITIES IN SPONDYLOARTHRITIS: DATA FROM THE MOROCCAN RBSMR REGISTRY

20. AB0444 SAFETY PROFILE OF BIOLOGICAL THERAPY IN RHEUMATOID ARTHRITIS IN MOROCCO. DATA FROM THE RBSMR

24. Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies, données du registre marocain des biothérapies (RBSMR)

25. Étude en double aveugle, contrôlée, randomisée, évaluant l’efficacité thérapeutique d’un retraitement par rituximab a la dose 500 mg×1 vs 500 mg×2 vs 1 g×1 chez les patients atteints de polyarthrite rhumatoïde : données préliminaires à 6 mois

27. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey

28. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

29. Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study

32. COVAD survey 2 long-term outcomes: unmet need and protocol

33. TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES : RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS

35. AB0867 Particularities of uveitis associated with spondyloarthritis: Data from the moroccan RBSMR registry

36. OP0161 TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS

37. AB0374 EFFICACY AND SAFETY OF BIOTHERAPY IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE MOROCCAN RBSMR REGISTRY

39. COVID-19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies

40. Le rituximab dans la vraie vie : données du registre de biothérapie de la Société Marocaine de Rhumatologie, RBSMR

41. Les spondyloarthrites à début tardif

42. Acceptabilité de la vaccination contre la Covid-19 chez les patients atteints de maladies rhumatismales chroniques et les professionnels de santé

43. Le risque infectieux sous anti-TNFα dans le registre de biothérapie de la Société marocaine de rhumatologie

46. AB0486 ONE-YEAR DIRECT COSTS OF BIOLOGICAL THERAPY IN ANKYLOSING SPONDYLITIS AND ITS PREDICTIVE FACTORS: DATA FROM THE MOROCCAN RBSMR REGISTRY

47. AB0485 DOES THE REASON OF DISCONTINUATION OF THE FIRST TNF INHIBITOR INFLUENCE THE RESPONSE TO THE SECOND TNF INHIBITOR IN SPONDYLOARTHRITIS? PILOT STUDY FROM THE MOROCCAN RBSMR REGISTRY

48. AB0811 DIRECT COST OF BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS IN A DEVELOPING COUNTRY: RESULTS FOR THE MOROCCAN RBSMR REGISTRY

49. AB0246 COMORBIDITIES APPEARING UNDER BIOLOGIC THERAPY: PREVALENCE AND ASSOCIATED FACTORS

50. POS1417 DO SOCIAL FACTORS IMPACT ON BIOLOGICS COSTS IN RHEUMATOID ARTHRITIS? RESULTS FROM THE MOROCCAN RBSMR REGISTRY

Catalog

Books, media, physical & digital resources